Correlation Between Salesforce and INtRON Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and iNtRON Biotechnology, you can compare the effects of market volatilities on Salesforce and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and INtRON Biotechnology.

Diversification Opportunities for Salesforce and INtRON Biotechnology

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Salesforce and INtRON is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of Salesforce i.e., Salesforce and INtRON Biotechnology go up and down completely randomly.

Pair Corralation between Salesforce and INtRON Biotechnology

Considering the 90-day investment horizon Salesforce is expected to generate 0.97 times more return on investment than INtRON Biotechnology. However, Salesforce is 1.03 times less risky than INtRON Biotechnology. It trades about 0.4 of its potential returns per unit of risk. iNtRON Biotechnology is currently generating about -0.09 per unit of risk. If you would invest  28,676  in Salesforce on August 25, 2024 and sell it today you would earn a total of  5,526  from holding Salesforce or generate 19.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  iNtRON Biotechnology

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
iNtRON Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iNtRON Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Salesforce and INtRON Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and INtRON Biotechnology

The main advantage of trading using opposite Salesforce and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.
The idea behind Salesforce and iNtRON Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets